Literature DB >> 7479861

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

M Nakajima1, H G Hutchinson, M Fujinaga, W Hayashida, R Morishita, L Zhang, M Horiuchi, R E Pratt, V J Dzau.   

Abstract

The type 1 angiotensin II (AT1) receptor is well characterized but the type 2 (AT2) receptor remains an enigma. We tested the hypothesis that the AT2 receptor can modulate the growth of vascular smooth muscle cells by transfecting an AT2 receptor expression vector into the balloon-injured rat carotid artery and observed that overexpression of the AT2 receptor attenuated neointimal formation. In cultured smooth muscle cells, AT2 receptor transfection reduced proliferation and inhibited mitogen-activated protein kinase activity. Furthermore, we demonstrated that the AT2 receptor mediated the developmentally regulated decrease in aortic DNA synthesis at the latter stages of gestation. These results suggest that the AT2 receptor exerts an antiproliferative effect, counteracting the growth action of AT1 receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479861      PMCID: PMC40672          DOI: 10.1073/pnas.92.23.10663

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Insulin and 12-O-tetradecanoylphorbol-13-acetate activation of two immunologically distinct myelin basic protein/microtubule-associated protein 2 (MBP/MAP2) kinases via de novo phosphorylation of threonine and tyrosine residues.

Authors:  K Tobe; T Kadowaki; H Tamemoto; K Ueki; K Hara; O Koshio; K Momomura; Y Gotoh; E Nishida; Y Akanuma
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

2.  Angiotensin II receptor subtypes play opposite roles in regulating phosphatidylinositol hydrolysis in rat skin slices.

Authors:  R Gyurko; B Kimura; P Kurian; F T Crews; M I Phillips
Journal:  Biochem Biophys Res Commun       Date:  1992-07-15       Impact factor: 3.575

3.  Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.

Authors:  R D Farhy; O A Carretero; K L Ho; A G Scicli
Journal:  Circ Res       Date:  1993-06       Impact factor: 17.367

4.  Changes in expression of angiotensin receptor subtypes in the rat aorta during development.

Authors:  M Viswanathan; K Tsutsumi; F M Correa; J M Saavedra
Journal:  Biochem Biophys Res Commun       Date:  1991-09-30       Impact factor: 3.575

5.  Expression of AT2 receptors in the developing rat fetus.

Authors:  E F Grady; L A Sechi; C A Griffin; M Schambelan; J E Kalinyak
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

6.  Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development.

Authors:  M A Millan; D M Jacobowitz; G Aguilera; K J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

7.  Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury.

Authors:  M F Prescott; R L Webb; M A Reidy
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

8.  Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing.

Authors:  M Viswanathan; J M Saavedra
Journal:  Peptides       Date:  1992 Jul-Aug       Impact factor: 3.750

9.  Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II.

Authors:  Y Koibuchi; W S Lee; G H Gibbons; R E Pratt
Journal:  Hypertension       Date:  1993-06       Impact factor: 10.190

10.  The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

Authors:  M Stoll; U M Steckelings; M Paul; S P Bottari; R Metzger; T Unger
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  84 in total

1.  The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: lessons learned from transgenic mice.

Authors:  C D Searles; D G Harrison
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

Review 3.  Novel actions of angiotensin II via its renal type-2 (AT(2)) receptor.

Authors:  R M Carey; Z Q Wang; H M Siragy
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

4.  Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study.

Authors:  S Busche; S Gallinat; R M Bohle; A Reinecke; J Seebeck; F Franke; L Fink; M Zhu; C Sumners; T Unger
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

5.  Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements.

Authors:  C Warnecke; T Willich; J Holzmeister; S P Bottari; E Fleck; V Regitz-Zagrosek
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 6.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

Review 7.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

8.  No evidence for angiotensin type 2 receptor gene polymorphism in intron 1 in patients with coarctation of the aorta and Ullrich-Turner syndrome.

Authors:  E Struwe; K Krammer; J Dötsch; M Metzler; H G Dörr; R Cesnjevar; W Rascher; A Koch
Journal:  Pediatr Cardiol       Date:  2006-08-30       Impact factor: 1.655

Review 9.  [The renin-angiotensin system in cardiovascular diseases].

Authors:  C Unterberg; H Kreuzer; A B Buchwald
Journal:  Med Klin (Munich)       Date:  1998-07-15

Review 10.  Are angiotensin receptor blockers neuroprotective?

Authors:  Christa Thöne-Reineke; Mathias Zimmermann; Christian Neumann; Maxim Krikov; Jun Li; Nadja Gerova; Thomas Unger
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.